Main Page Content

Putting the Puzzle Together
Dr. Nigil Haroon

​​​​​​​Dr. Nigil Haroon’s research findings suggest that patients with Ankylosing Spondylitis receive comprehensive screening, preventative care, as well as optimal management of cardiovascular and cerebrovascular disease.​

Research links Ankylosing Spondylitis to cardiovascular mortality

A new study published in the Annals of Internal Medicine has revealed that people diagnosed with Ankylosing Spondylitis (AS), the most common form of inflammatory arthritis affecting the spine, have a higher risk of dying from a heart attack or stroke than the general population.​

Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study, links AS with a 35 per cent higher risk of dying from heart attack and a 60 percent increased risk of dying from stroke than those without AS.

​​“We performed what we believe to be the first large population-​​based study on this subject matter,” says Dr. Nigil Haroon, the study’s senior author and staff rheumatologist in the Arthritis Program at Toronto Western Hospital. Commencing in 1995, the study included over 21,000 AS patients and 86,000 controls without AS, to determine the level of mortality risk AS patients face.